← Open Payments lookup

MARY CARRASCO: Open Payments

NPI 1255981122 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$202 in 10 payments from 5 companies in 2025. Trend: 2023 $925 · 2024 $348 · 2025 $202

Food & beverage: $202
CompanyPaymentsAmount
ABBVIE INC.4$89
Sumitomo Pharma America, Inc.2$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$31
Amgen Inc.1$22
Otsuka America Pharmaceutical, Inc.1$22

Products named: LINZESS, GEMTESA, QULIPTA, XIFAXAN, REPATHA, REXULTI.

Industry payments across CO — which companies pay providers there.